Next Article in Journal
Microbial C and N Metabolism Alterations Based on Soil Metagenome and Different Shrub Invasion Stages in Sanjiang Plain Wetlands
Previous Article in Journal
Nisin, a Probiotic Bacteriocin, Modulates the Inflammatory and Microbiome Changes in Female Reproductive Organs Mediated by Polymicrobial Periodontal Infection
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Commentary

Dual Role of Cutibacterium acnes: Commensal Bacterium and Pathogen in Ocular Diseases

1
Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto 602-0841, Japan
2
Department of Ophthalmology, Kyoto City Hospital Organization, Kyoto 604-8845, Japan
3
Department of Frontier Medical Science and Technology for Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto 602-0841, Japan
*
Author to whom correspondence should be addressed.
Microorganisms 2024, 12(8), 1649; https://doi.org/10.3390/microorganisms12081649
Submission received: 30 June 2024 / Revised: 5 August 2024 / Accepted: 9 August 2024 / Published: 12 August 2024
(This article belongs to the Special Issue Cutibacterium acnes Infection and Immunity)

Abstract

:
Microbiota present around the ocular surface, encompassing the eyelid skin, the conjunctival sac, and the meibomian glands, play a significant role in various inflammatory conditions associated with the ocular surface. Cutibacterium acnes (C. acnes), formerly, Propionibacterium acnes, is one of the most predominant commensal bacteria and its relative abundance declines with aging. However, it can act as both an infectious and an immunogenic pathogen. As an infectious pathogen, C. acnes has been reported to cause late onset endophthalmitis post-cataract surgery and infectious keratitis. On the other hand, it can trigger immune responses resulting in conditions such as phlyctenules in the cornea, chalazion in the meibomian glands, and granuloma formation in ocular sarcoidosis. This review explores the role of C. acnes in ocular inflammation, specifically highlighting its implications for diagnosis and management.

1. Introduction

The ocular surface is constantly exposed to the environment, and a variety of bacteria inhabit it. These bacteria are known to be involved in maintaining homeostasis and contributing to various pathological conditions. The microbiota of the ocular surface is controlled by antimicrobial components such as IgA [1], lysozyme [1], lactoferrin [2], and defensins [3], which are secreted by lacrimal glands, accessory lacrimal glands, and conjunctival epithelium including goblet cells. Additionally, antimicrobial substances from meibum (the secretion from the meibomian glands) also play a role [4]. Therefore, not only the conjunctiva but also the tear film and surrounding eyelid margin, including the meibomian glands and eyelid skin, influence the composition of microbes on the ocular surface. Since the 19th century, numerous studies have been performed on the microbiota of the ocular surface using traditional bacterial cultures. Overall, these findings revealed that, in healthy subjects, the most commonly isolated aerobes are coagulase-negative staphylococci (CoNS), and the most commonly isolated anaerobes are Cutibacterium acnes (C. acnes), formerly Propionibacterium acnes (P. acnes) [5,6]. Corynebacterium spp. and Staphylococcus aureus (S. aureus) are less commonly isolated bacteria [5]. Recent 16S rRNA sequencing techniques have revealed that the microbiota of the conjunctiva and meibum in healthy adult subjects is highly diverse, with C. acnes being the most abundant; however, this diversity declines with aging [7].
C. acnes is a lipophilic Gram-positive bacillus which normally inhabits human sebaceous follicles [8]. C. acnes is considered an anaerobic aerotolerant as it possesses enzymes such as superoxide dismutase and peroxidase, to detoxify oxygen, allowing it to grow in the presence of oxygen [9]. It is well-known for its central role in the production of acne lesions in acne vulgaris [10]. In addition, C. acnes is implicated in a variety of clinical conditions, particularly those associated with medical devices and surgical procedures [11,12]. In the human eye, C. acnes has become known for its role as a causative bacterium in conditions such as late-onset endophthalmitis post-cataract surgery [13,14,15,16], infectious keratitis, particularly due to contact lens wear [17,18,19], meibomitis-related keratoconjunctivitis [20,21,22], chalazia [23], and granuloma formation in the retina of ocular sarcoidosis [24,25].
For a microbiological diagnosis, C. acnes is typically cultured on anaerobic blood agar [26], and it requires a minimum incubation period of 7 days [27]. In the field of ophthalmology, specimens obtained from sources such as corneal ulcers or vitreous fluid are usually very small, and the yield for detecting even obvious infections, such as infectious keratitis (52%) [28] and postoperative endophthalmitis (70%) [29], is relatively low. In contrast, polymerase chain reaction (PCR) is a more useful method for rapid and sensitive diagnosis compared to traditional culture techniques [30]. However, it has the disadvantage of a high rate of false positives due to commensal or dead bacteria [30]. Thus, the accurate identification of C. acnes is essential for proper diagnosis.
This review explores the dual role of C. acnes as both a commensal bacterium and a pathogen, acting as both an infectious agent and a trigger of inflammation in ocular diseases. By shedding light on the implications of C. acnes in the diagnosis and management of ocular inflammation, this review aims to enhance our understanding and lead to more targeted and effective therapeutic strategies.

2. C. acnes as a Commensal Bacterium on the Ocular Surface and Eyelid Margin

Numerous studies have investigated the bacteriology of the conjunctiva using traditional bacterial cultures. Anaerobes such as C. acnes, which typically appear in cultures after approximately 7 days [27], were initially overlooked by standard methods in previous years. In 1974, C. acnes was identified as a major component of normal skin and ocular flora [31]. It has been consistently recovered from the conjunctiva of healthy individuals [32] and the eyelid margin [33] along with aerobic bacteria such as Staphylococcus spp. and Corynebacterium spp. C. acnes is also found in meibum, albeit less frequently than coagulase-negative staphylococci (CoNS), which are predominant aerobes [33]. These findings have remained consistent in subsequent studies [5,34].
Since the early 21st century, microbiome research has advanced significantly with the advent of 16S rRNA gene sequencing. A recent study has shown that, in newborns, the conjunctival microbiome is primarily composed of Proteobacteria, followed by Actinobacteria and Firmicutes, with C. acnes being the most abundant bacterium [35]. An adult healthy conjunctiva is predominantly composed of Firmicutes, Actinobacteria, and Proteobacteria [36,37]. When compared to the microbiome of the eyelid skin, conjunctival sac, and meibum in the same eye in healthy young adults, both the conjunctival and meibum microbiomes exhibit a high alpha-diversity with C. acnes predominating [7]. In contrast, healthy elderly adults show a microbiome more similar to that of the eyelid skin, with approximately 30% displaying a low diversity of microbiomes dominated by Corynebacterium spp. or Neisseriaceae [7]. The microbiome of eyelid skin is relatively simple and typically dominated by C. acnes in the young but dominated by Corynebacterium spp. or Neisseriaceae in the elderly [7]. Although there are clear age-related differences, sex differences appear to be insignificant [7]. Several studies have highlighted microbial compositional changes in conditions such as dry eye and meibomian gland dysfunction (MGD) [38,39,40]. Recently, the microbiome associated with MGD has been reported to exhibit an increased abundance of lipophilic Corynebacterium spp., such as C. macginleyi, compared to normal subjects [41]. Additionally, Pseudomonas becomes more prevalent in cases of MGD accompanied by lacrimal dysfunction, which may contribute to the development of conjunctivitis [41]. These changes are often accompanied by a relative decline in the abundance of C. acnes, suggesting that C. acnes might play an important role in maintaining homeostasis on the ocular surface and eyelids.

3. C. acnes as an Infectious Pathogen: Postoperative Endophthalmitis and Keratitis

Although C. acnes is one of the most predominant commensal bacteria on the healthy ocular surface, it can be an infectious pathogen. The first case series of chronic endophthalmitis after extracapsular cataract extraction and intraocular lens (IOL) implantation caused by C. acnes was published in 1986 [13]. This condition is characterized by a white, intracapsular plaque composed of sequestered organisms in the relatively anaerobic peripheral capsular bag [16]. Since then, about 100 cases have been reported over eight case series [13,14,15,16,42]. The inflammation caused by C. acnes typically has a delayed onset compared to that caused by other common bacteria, such as CoNS [43]. This delay is due to C. acnes’s slow proliferation as an anaerobic microbe and its resistance to killing and degradation by neutrophils and monocytes [44]. Although the exact incidence of C. acnes endophthalmitis is not well-defined, chronic onset endophthalmitis following cataract surgery has been reported at a rate of 0.017% [45]. Diagnosis can be made through traditional anaerobic bacterial culture and/or PCR from aqueous and/or vitreous samples. Cultures take up to a week to yield results. In contrast, PCR offers advantages over bacterial cultures; for example, C. acnes was identified in 94% of vitreous samples by PCR compared to only 24% by culturing, whereas culturing identified C. acnes in 0% of aqueous samples [46]. Bacterial cultures obtained from undergone vitrectomy proved the presence of C. acnes in the vitreous and capsule and were shown to inhibit CD8+ T cells, which may play a role in the persistent inflammation in cases of C. acnes endophthalmitis [47]. The treatment is sometimes not successful because inflammation can recur many months and years after the initial treatment. The administration of topical and intraocular antimicrobial agents alone typically does not eradicate the organism because C. acnes can produce biofilms. These biofilms have been observed on the IOL haptics using scanning electron microscopy (SEM) [48] and can also become encapsulated in the peripheral capsule. Case reports of endophthalmitis due to C. acnes after an Nd: YAG capsulotomy [14,16] suggest the existence of C. acnes in the capsular bag with the IOL. Therefore, pars plana vitrectomy (PPV) and IOL extraction with antimicrobial treatment have been recognized as effective treatments [16,42].
C. acnes can also cause infectious keratitis. The first report was published in 1992 [17]. The characteristic findings are small ulcers with deep stromal infiltration evenly distributed in the cornea associated with anterior chamber cell reaction [17,18,19]. To identify C. acnes, an anaerobic bacterial culture is required with a minimum of 7 days of incubation. The risk factors for C. acnes keratitis (CAK) are considered to be similar to those of other infectious keratitis such as contact lens usage, ocular trauma, and ocular surgery. C. acnes is generally susceptible to most antimicrobial agents, including cephalosporins, fluoroquinolones, tetracyclines, erythromycin, vancomycin, and clindamycin [49]. However, recent findings indicate that it has developed varying degrees of resistance to clindamycin, macrolides, and tetracyclines [50]. For the topical treatment of CAK, fluoroquinolones are used extensively [51]. However, vancomycin is reportedly the most effective antimicrobial agent, as it has a lower minimum bactericidal concentration against C. acnes compared to other antimicrobial agents [19,52]. The visual prognosis is usually good in mild to moderate cases; however, it could be worse in severe cases [19].

4. C. acnes as a Trigger of Inflammation: Meibomitis-Related Keratoconjunctivitis (MRKC), Chalazion, and Ocular Sarcoidosis

Previous studies revealed that C. acnes is a potent inflammatory stimulus that can activate complement [53], produce serum-independent polymorphonuclear leukocyte (PMN) chemotactic factors [54], stimulate the release of lysosomal enzyme from human PMN [55], and selectively inhibit suppressor/cytotoxic T lymphocytes [56,57]. Furthermore, C. acnes has been used in animal models to induce granulomas in the lung, liver, and cornea [58,59,60]. Granuloma is a result of a chronic delayed-type hypersensitivity (DTH) response.

4.1. MRKC

C. acnes is a commensal bacterium in the meibomian glands [7,33,34]. They are modified sebaceous glands which produce and secrete lipids onto the eyelid margin, spreading onto the aqueous layer of tear film. It is now widely recognized that the condition of the meibomian gland has a direct impact on the ocular surface condition. Phlyctenular keratitis (PK), which is a disorder characterized by inflammatory corneal nodules predominantly in young females, has been reportedly recognized as phlyctenular-type of meibomitis-related keratoconjunctivitis (MRKC) since corneal phlyctenules (cellular infiltrates) are often located at the extension of meibomitis [20,21,22,61]. Bacterial culture of meibum from PK was highly positive for C. acnes compared with that from age-matched females [20,22]. Laboratory research has proven that C. acnes can induce DTH response in the rat cornea; heat-killed C. acnes can induce inflammatory cellular infiltration in the C. acnes-immunized rat cornea [60]. An immunohistochemical study revealed that CD4+ T cells infiltrated predominately over CD8+ T cells [60], a finding which is compatible with those of immunohistochemical studies of conjunctival phlyctenules [62]. Therefore, C. acnes can be causative for both meibomitis and corneal/conjunctival phlyctenules (cellular infiltrates) in MRKC. There seems to be a specific human leukocyte antigen (HLA), such as HLA-A26, B-35, or DRB1*0802, which is associated with C. acnes involvement [20]. Based on these findings, antimicrobial treatment specifically targeting C. acnes is essential and effective in curing phlyctenular-MRKC [20,21,22]. Phlyctenular-MRKC shares common clinical characteristics (female predominance, bilateral involvement, history of chalazia, and effectiveness of antimicrobial treatment) with childhood ocular rosacea, phlyctenular keratoconjunctivitis, and pediatric blepharokeratoconjunctivitis (PBKC) [20]. In 2024, an international consensus was reached on the definition and diagnostic criteria, widely defining these diseases as “PBKC” [63]. PBKC is often overlooked but is a sight-threatening inflammatory ocular surface disease, so it is important to consider C. acnes involvement when encountering corneal infiltrates with meibomitis.

4.2. Chalazion

Chalazion is a chronic inflammatory granuloma caused primarily by the obstruction of the meibomian gland orifices leading to the retention of meibum [64]. Histological examinations in the 19th century revealed its granulomatous nature, and its pathogenesis has been widely accepted as a foreign-body granuloma due to the degeneration products of meibum, i.e., “lipo-granuloma” [64]. Several pathogens had been proposed as risk factors for chalazion; however, no pathogenic bacteria had been proven to be causative until recently. Patients with phlyctenular-MRKC often have a history of chalazia [20,22]. An immunohistochemical examination using a P. acnes-specific monoclonal antibody (PAB antibody) [65] on chalazion tissues obtained from surgeries revealed positive staining for C. acnes, with these bacteria amid clusters of neutrophils as well as epithelioid macrophages and lymphocytes, i.e., “immune granuloma” [23]. This was the first report which implies the possible role of anaerobic C. acnes in granuloma formation in chalazion. The characteristic of C. acnes resistant to killing and degradation by human neutrophils and monocytes results in long-standing inflammation or granuloma development in the meibomian glands. For the treatment of chalazion, not only steroid usage to reduce the immune reaction but elimination of C. acnes with antimicrobial agents is effective.

4.3. Ocular Sarcoidosis

A preliminary case series study using PCR techniques on vitreous samples supports the involvement of Propionibacterium species in ocular sarcoidosis [66]. Later, two studies were conducted to explore C. acnes involvement in sarcoid granuloma in the retina [24,25]. The specimens obtained from vitrectomy were examined immunohistochemically with PAB antibody [24,25]. They contained the granulomas which were mainly observed in the inner retinal layer filled with CD4+ cells and CD68+ cells, indicating the Th1 immune response [25]. C. acnes has been isolated at a high ratio from the lymph nodes of the pulmonary hilum in the sarcoidosis patients compared to those from the patients with other disease, which leads C. acnes be recognized as the most implicated etiological bacterium for sarcoidosis in Japanese patients [67,68]. Obviously, C acnes is not commensal in the retina and the mechanism by which C. acnes reaches the retina is not clear. One possibility is that granulomas were caused by the hematogenous transmission of C. acnes as C. acnes was mainly detected in the granulomas in the inner retinal layer, where retinal vessels are mainly distributed [25].

5. Pathogenesis for Granuloma Formation for Chalazion and Sarcoidosis

Although C. acnes plays a significant role as a trigger for granuloma formation in both chalazion and sarcoid granuloma, the pathogenesis of these granulomas differs. Sarcoidosis is a systemic inflammatory disease characterized by the formation of noncaseating epithelioid granulomas in multiple organs, including the lungs and eyes [69]. Granuloma formation is a cellular attempt to contain an offending agent that is difficult to eradicate [70]. Foreign body granulomas are formed by agents with weak antigenicity, while epithelioid cell granulomas are formed by agents with strong antigenicity inducing Th1 immune response [71]. In patients with Th1 hypersensitivity to C. acnes, granulomatous inflammation is triggered by intracellular proliferation of the bacterium, resulting in granuloma formation [72]. In contrast, C. acnes does not appear to cause intracellular infection in chalazion, as clusters of C. acnes are surrounded by neutrophils and epithelioid cells [23]. This could explain the focal inflammation of the meibomian glands.

6. Conclusions

In summary, C. acnes is the most predominant anaerobic bacterium on the ocular surface and eyelid. As a commensal bacterium, it contributes to ocular surface homeostasis. However, it can also act as an infectious pathogen, causing late-onset postoperative endophthalmitis and keratitis, or as a trigger of immunoreactions resulting in long-lasting inflammation and granuloma formation on the cornea, meibomian glands, and retina. Managing inflammation and eliminating C. acnes is an effective treatment for curing infections and granulomas.

Author Contributions

Conceptulization, T.S. and S.K.; writing—original draft preparation, T.S.; writing—review and editing, T.S.; supervision, S.K. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Vinding, T.; Eriksen, J.S.; Nielsen, N.V. The concentration of lysozyme and secretory IgA in tears from healthy persons with and without contact lens use. Acta Ophthalmol. 1987, 65, 23–26. [Google Scholar] [CrossRef] [PubMed]
  2. Jensen, O.L.; Gluud, B.S.; Birgens, H.S. The concentration of lactoferrin in tears of normals and of diabetics. Acta Ophthalmol. 1986, 64, 83–87. [Google Scholar] [CrossRef] [PubMed]
  3. Haynes, R.J.; Tighe, P.J.; Dua, H.S. Antimicrobial defensin peptides of the human ocular surface. Br. J. Ophthalmol. 1999, 83, 737–741. [Google Scholar] [CrossRef] [PubMed]
  4. Mudgil, P. Antimicrobial role of human meibomian lipids at the ocular surface. Investig. Ophthalmol. Vis. Sci. 2014, 55, 7272–7277. [Google Scholar] [CrossRef]
  5. Willcox, M.D. Characterization of the normal microbiota of the ocular surface. Exp. Eye Res. 2013, 117, 99–105. [Google Scholar] [CrossRef]
  6. Scholz, C.F.P.; Kilian, M. The natural history of cutaneous propionibacteria, and reclassification of selected species within the genus Propionibacterium to the proposed novel genera Acidipropionibacterium gen. nov., Cutibacterium gen. nov. and Pseudopropionibacterium gen. nov. Int. J. Syst. Evol. Microbiol. 2016, 66, 4422–4432. [Google Scholar] [CrossRef] [PubMed]
  7. Suzuki, T.; Sutani, T.; Nakai, H.; Shirahige, K.; Kinoshita, S. The microbiome of the meibum and ocular surface in healthy subjects. Investig. Ophthalmol. Vis. Sci. 2020, 61, 18. [Google Scholar] [CrossRef] [PubMed]
  8. Leeming, J.P.; Holland, K.T.; Cunliffe, W.J. The microbial ecology of pilosebaceous units isolated from human skin. J. Gen. Microbiol. 1984, 130, 803–807. [Google Scholar] [CrossRef] [PubMed]
  9. Gajdacs, M.; Spengler, G.; Urban, E. Identification and Antimicrobial Susceptibility Testing of Anaerobic Bacteria: Rubik’s Cube of Clinical Microbiology? Antibiotics 2017, 6, 25. [Google Scholar] [CrossRef]
  10. Tuchayi, M.S.; Makrantonaki, E.; Ganceviciene, R.; Dessinioti, C.; Feldman, S.R.; Zouboulis, C.C. Acne vulgaris. Nat. Rev. Dis. Primers 2015, 1, 15029. [Google Scholar] [CrossRef]
  11. Perry, A.; Lambert, P. Propionibacterium acnes: Infection beyond the skin. Expert Rev. Anti-Infect. Ther. 2011, 9, 1149–1156. [Google Scholar] [CrossRef] [PubMed]
  12. Boisrenoult, T. Cutibacterium acnes prosthetic joint infection: Diagnosis and treatment. Orthop. Traumatol. Surg. Res. 2018, 104, S19–S24. [Google Scholar] [CrossRef] [PubMed]
  13. Jaffe, G.J.; Whitcher, J.P.; Biswell, R.; Irvine, A.R. Propionibacterium acnes endophthalmitis seven months after extracapsular cataract extraction and intraocular lens implantation. Ophthalmic Surg. 1986, 17, 791–793. [Google Scholar] [CrossRef] [PubMed]
  14. Meisler, D.M.; Palestine, A.G.; Vastine, D.W.; Demartini, D.R.; Murphy, B.F.; Reinhart, W.J.; Zakov, Z.N.; McMahon, J.T.; Cliffel, T.P. Chronic Propionibacterium endophthalmitis after extracapsular cataract extraction and intraocular lens implantation. Am. J. Ophthalmol. 1986, 102, 733–739. [Google Scholar] [CrossRef] [PubMed]
  15. Roussel, T.J.; Culbertson, W.W.; Jaffe, N.S. Chronic postoperative endophthalmitis associated with Propionibacterium acnes. Arch. Ophthalmol. 1987, 105, 1199–1201. [Google Scholar] [CrossRef] [PubMed]
  16. Fowler, B.J.; Miller, D.; Yan, X.; Yannuzzi, N.A.; Flynn, H.W., Jr. Postoperative Endophthalmitis Caused by Cutibacterium (Formerly Propionibacterium) Acnes: Case Series and Review. Case Rep. Ophthalmol. 2021, 12, 1–10. [Google Scholar] [CrossRef] [PubMed]
  17. Zaidman, G.W. Propionibacterium acnes keratitis. Am. J. Ophthalmol. 1992, 113, 596–598. [Google Scholar] [CrossRef] [PubMed]
  18. Lim, S.A.; Na, K.S.; Joo, C.K. Clinical Features of Infectious Keratitis Caused by Propionibacterium acnes. Eye Contact Lens 2017, 43, 330–333. [Google Scholar] [CrossRef] [PubMed]
  19. Ashby, N.S.; Johnson, T.J.; Castillo-Ronquillo, Y.; Payne, C.J.; Davenport, C.; Hoopes, P.C.; Moshirfer, M. Cutibacterium (Formerly Propionibacterium) acnes Keratitis: A Review. Eye Contact Lens 2023, 49, 212–218. [Google Scholar] [CrossRef]
  20. Suzuki, T.; Mitsuishi, Y.; Sano, Y.; Yokoi, N.; Kinoshita, S. Phlyctenular keratitis associated with meibomitis in young patients. Am. J. Ophthalmol. 2005, 140, 77–82. [Google Scholar] [CrossRef]
  21. Suzuki, T. Meibomitis-related keratoconjunctivitis: Implications and clinical significance of meibomian gland inflammation. Cornea 2012, 31 (Suppl. S1), S41–S44. [Google Scholar] [CrossRef] [PubMed]
  22. Suzuki, T.; Teramukai, S.; Kinoshita, S. Meibomian glands and ocular surface inflammation. Ocul. Surf. 2015, 13, 133–149. [Google Scholar] [CrossRef] [PubMed]
  23. Suzuki, T.; Katsuki, N.; Tsutsumi, R.; Uchida, K.; Ohashi, K.; Eishi, Y.; Kinoshita, S. Reconsidering the pathogenesis of chalazion. Ocul. Surf. 2022, 24, 31–33. [Google Scholar] [CrossRef] [PubMed]
  24. Goto, H.; Usui, Y.; Umazume, A.; Uchida, K.; Eishi, Y. Propionibacterium acnes as a possible pathogen of granuloma in patients with ocular sarcoidosis. Br. J. Ophthalmol. 2017, 101, 1510–1513. [Google Scholar] [CrossRef] [PubMed]
  25. Nagata, K.; Eishi, Y.; Uchida, K.; Yoneda, K.; Hatanaka, H.; Yasuhara, T.; Nagata, M.; Sotozono, C.; Kinoshita, S. Immunohistochemical Detection of Propionibacterium acnes in the Retinal Granulomas in Patients with Ocular Sarcoidosis. Sci. Rep. 2017, 7, 15226. [Google Scholar] [CrossRef] [PubMed]
  26. Ma, K.K.; Ung, L.; Chadoshl, J. Evidence-based management of culture negative antimicrobial. Int. Ophthalmol. Clin. 2022, 62, 111–124. [Google Scholar] [CrossRef] [PubMed]
  27. Hara, J.; Yasuda, F.; Higashitsutsumi, M. Preoperative disinfection of the conjunctival sac in cataract surgery. Ophthalmologica 1997, 211 (Suppl. S1), 62–67. [Google Scholar] [CrossRef]
  28. Kim, E.; Chidambaram, J.D.; Srinivasan, M.; Laitha, P.; Wee, D.; Lietman, M.T.; Whitcher, J.P.; Van Gleder, R.N. Prospective comparison of microbial culture and polymerase chain reaction in the diagnosis of corneal ulcer. Am. J. Ophthalmol. 2018, 146, 714–723. [Google Scholar] [CrossRef]
  29. Endophthalmitis Vitrectomy Study Group. Results of the Endophthalmitis Vitrectomy Study. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Arch. Ophthalmol. 1995, 113, 1479–1496. [Google Scholar] [CrossRef]
  30. Taravati, P.; Lam, D.; van Gelder, R.N. Role of molecular diagnostic in ocular microbiology. Curr. Ophthalmol. Rep. 2013, 1, 181–189. [Google Scholar] [CrossRef]
  31. Marples, R.R.; McGinley, K.J. Corynebacterium acnes and other anaerobic diphtheroids from human skin. J. Med. Microbiol. 1974, 7, 349–357. [Google Scholar] [CrossRef]
  32. Perkins, R.E.; Kundsin, R.B.; Pratt, M.V.; Abrahamsen, I.; Leibowitz, H.M. Bacteriology of normal and infected conjunctiva. J. Clin. Microbiol. 1975, 1, 147–149. [Google Scholar] [CrossRef]
  33. Dougherty, J.M.; McCulley, J.P. Comparative bacteriology of chronic blepharitis. Br. J. Ophthalmol. 1984, 68, 524–528. [Google Scholar] [CrossRef] [PubMed]
  34. Zhang, S.D.; He, J.N.; Niu, T.T.; Chan, C.Y.; Ren, C.Y.; Liu, S.S.; Qu, Y.; Chong, K.L.; Wang, H.L.; Tao, J.; et al. Bacteriological profile of ocular surface flora in meibomian gland dysfunction. Ocul. Surf. 2017, 15, 242–247. [Google Scholar] [CrossRef]
  35. Petrillo, F.; Petrillo, A.; Marrapodi, M.; Capristo, C.; Gicchino, M.F.; Montaldo, P.; Carreda, M.; Reibaldi, M.; Boatti, L.M.V.; Dell’Annunziata, F.; et al. Characterization and Comparison of Ocular Surface Microbiome in Newborns. Microorganisms 2022, 10, 1390. [Google Scholar] [CrossRef] [PubMed]
  36. de Paiva, C.S.; Jones, D.B.; Stern, M.E.; Bian, F.; Moore, Q.L.; Corbiere, S.; Streckfus, C.S.; Hutchinson, D.S.; Ajami, N.J.; Petrosino, J.F.; et al. Altered Mucosal Microbiome Diversity and Disease Severity in Sjogren Syndrome. Sci. Rep. 2016, 6, 23561. [Google Scholar] [CrossRef] [PubMed]
  37. Ozkan, J.; Nielsen, S.; Diez-Vives, C.; Coroneo, M.; Thomas, T.; Willcox, M. Temporal Stability and Composition of the Ocular Surface Microbiome. Sci. Rep. 2017, 7, 9880. [Google Scholar] [CrossRef]
  38. Zhao, F.; Zhang, D.; Ge, C.; Zhang, L.; Reinach, P.S.; Tian, X.; Tao, C.; Zhao, Z.; Zhao, C.; Fu, W.; et al. Metagenomic Profiling of Ocular Surface Microbiome Changes in Meibomian Gland Dysfunction. Investig. Ophthalmol. Vis. Sci. 2020, 61, 22. [Google Scholar] [CrossRef]
  39. Jiang, X.; Deng, A.; Yang, J.; Bai, H.; Yang, Z.; Wu, J.; Lv, H.; Li, X.; Wen, T. Pathogens in the Meibomian gland and conjunctival sac: Microbiome of normal subjects and patients with Meibomian gland dysfunction. Infect. Drug Resist. 2018, 11, 1729–1740. [Google Scholar] [CrossRef]
  40. Andersson, J.; Vogt, J.K.; Dalgaard, M.D.; Pedersen, O.; Holmgaard, K.; Heegaard, S. Ocular surface microbiota in patients with aqueous tear-deficient dry eye. Ocul. Surf. 2021, 19, 210–217. [Google Scholar] [CrossRef]
  41. Ozkan, J.; Majzoub, M.E.; Coroneo, M.; Thomas, T.; Willcox, M. Ocular microbiome changes in dry eye disease and meibomian gland dysfunction. Exp. Eye Res. 2023, 235, 109615. [Google Scholar] [CrossRef]
  42. Zambrano, W.; Flynn, H.W., Jr.; Pflugfelder, S.C.; Roussel, T.J.; Culbertson, W.W.; Holland, S.; Miller, D. Management options for Propionibacterium acnes endophthalmitis. Ophthalmology 1989, 96, 1100–1105. [Google Scholar] [CrossRef]
  43. Maalouf, F.; Abdulaal, M.; Hamam, R.N. Chronic postoperative endophthalmitis: A review of clinical characteristics, microbiology, treatment strategies, and outcomes. Int. J. Inflam. 2012, 2012, 313248. [Google Scholar] [CrossRef] [PubMed]
  44. Webster, G.F.; Leyden, J.J.; Musson, R.A.; Douglas, S.D. Susceptibility of Propionibacterium acnes to killing and degradation by human neutrophils and monocytes in vitro. Infect. Immunol. 1985, 49, 116–121. [Google Scholar] [CrossRef]
  45. Al-Mezaine, H.S.; Al-Assiri, A.; Al-Rajhi, A.A. Incidence, clinical features, causative organisms, and visual outcomes of delayed-onset pseudophakic endophthalmitis. Eur. J. Ophthalmol. 2009, 9, 804–811. [Google Scholar] [CrossRef] [PubMed]
  46. Lohmann, C.P.; Linde, H.J.; Reischl, U. Improved detection of microorganisms by polymerase chain reaction in delayed endophthalmitis after cataract surgery. Ophthalmology 2000, 107, 1047–1051, discussion 1051–1052. [Google Scholar] [CrossRef]
  47. Whitcup, S.M.; Belfort, R., Jr.; de Smet, M.D.; Palestine, A.G.; Nussenblatt, R.B.; Chan, C.C. Immunohistochemistry of the inflammatory response in Propionibacterium acnes endophthalmitis. Arch. Ophthalmol. 1991, 109, 978–979. [Google Scholar] [CrossRef]
  48. Hayashi, Y.; Eguchi, H.; Miyamoto, T.; Inoue, M.; Mitamura, Y. A Case of Delayed-Onset Propionibacterium acnes Endophthalmitis after Cataract Surgery with Implantation of a Preloaded Intraocular Lens. Case Rep. Ophthalmol. 2012, 3, 291–297. [Google Scholar] [CrossRef] [PubMed]
  49. Denys, G.A.; Jerris, R.C.; Swenson, J.M.; Thornsberry, C. Susceptibility of Propionibacterium acnes clinical isolates to 22 antimicrobial agents. Antimicrob. Agents Chemother. 1983, 23, 335–337. [Google Scholar] [CrossRef]
  50. Boyanova, L. Cutibacterium acnes (formerly Propionibacterium acnes): Firend or foe? Future Microbiol. 2023, 18, 2350244. [Google Scholar] [CrossRef]
  51. Agarwal, S.; Kahn, T.A.; Vanathi, M.; Srinivasan, B.; Lyer, G.; Tandon, R. Update on diagnosis and management of refractory corneal infections. Indian J. Ophthalmol. 2022, 70, 1475–1490. [Google Scholar] [CrossRef] [PubMed]
  52. Hall, G.S.; Pratt-Rippin, K.; Meisler, D.M.; Washington, G.S.; Roussel, G.S.; Miller, D. Minimum bactericidal concentrations of Propionibacterium acnes isolates from cases of chronic endophthalmitis. Diagn. Microbiol. Infect. Dis. 1995, 21, 187–190. [Google Scholar] [CrossRef] [PubMed]
  53. Webster, G.F.; Leyden, J.J.; Norman, M.E.; Nilsson, U.R. Complement activation in acne vulgaris: In vitro studies with Propionibacterium acnes and Propionibacterium granulosum. Infect. Immun. 1978, 22, 523–529. [Google Scholar] [CrossRef]
  54. Puhvel, S.M.; Sakamoto, M. The chemoattractant properties of comedonal components. J. Investig. Dermatol. 1978, 71, 324–329. [Google Scholar] [CrossRef] [PubMed]
  55. Webster, G.F.; Leyden, J.J.; Tsai, C.C.; Baehni, P.; McArthur, W.P. Polymorphonuclear leukocyte lysosomal release in response to Propionibacterium acnes in vitro and its enhancement by sera from inflammatory acne patients. J. Investig. Dermatol. 1980, 74, 398–401. [Google Scholar] [CrossRef]
  56. Knop, J.; Riechmann, R.; Macher, E. Modulation of suppressor mechanisms in allergic contact dermatitis: 1. Effect of C. parvum on the induction phase of contact allergy. J. Investig. Dermatol. 1981, 76, 193196. [Google Scholar] [CrossRef]
  57. Knop, J.; Riechmann, R.; Macher, E. Modulation of suppressor mechanism in allergic contact dermatitis. IV. Selective inhibition of suppressor T-lymphocytes by serum obtained from Corynebacterium parvum treated mice. J. Investig. Dermatol. 1981, 77, 469–473. [Google Scholar] [CrossRef]
  58. Senaldi, G.; Yin, S.; Shaklee, C.L.; Piguet, P.F.; Mak, T.W.; Ulich, T.R. Corynebacterium parvum- and Mycobacterium bovis bacillus Calmette-Guerin-induced granuloma formation is inhibited in TNF receptor I (TNF-RI) knockout mice and by treatment with soluble TNF-RI. J. Immunol. 1996, 157, 5022–5026. [Google Scholar] [CrossRef]
  59. Yi, E.S.; Lee, H.; Suh, Y.K.; Tang, W.; Qi, M.; Yin, S.; Remick, D.G.; Ulich, T.R. Experimental extrinsic allergic alveolitis and pulmonary angiitis induced by intratracheal or intravenous challenge with Corynebacterium parvum in sensitized rats. Am. J. Pathol. 1996, 149, 1303–1312. [Google Scholar]
  60. Suzuki, T.; Sano, Y.; Sasaki, O.; Kinoshita, S. Ocular surface inflammation induced by Propionibacterium acnes. Cornea 2002, 21, 812–817. [Google Scholar] [CrossRef]
  61. Suzuki, T.; Kinoshita, S. Meibomitis-related keratoconjunctivitis in childhood and adolescence. Am. J. Ophthalmol. 2007, 144, 160–161. [Google Scholar] [CrossRef] [PubMed]
  62. abu el-Asrar, A.M.; Van den Oord, J.J.; Geboes, K.; Facchetti, F.; Missotten, L.; Emarah, M.H.; Desmet, V. Phenotypic characterization of inflammatory cells in phlyctenular eye disease. Doc. Ophthalmol. 1988, 70, 353–362. [Google Scholar] [CrossRef] [PubMed]
  63. Morales-Mancillas, N.R.; Velazquez-Valenzuela, F.; Kinoshita, S.; Suzuki, T.; Dahlmann-Noor, A.H.; Dart, J.K.G.; Hingorani, M.; Ali, A.; Fung, S.; Akova, Y.A.; et al. Definition and Diagnostic Criteria for Pediatric Blepharokeratoconjunctivitis. JAMA Ophthalmol. 2024, 142, 39–47. [Google Scholar] [CrossRef] [PubMed]
  64. Duke-Elder, W.S.; Mac-Faul, P.A. The Ocular Adnexa, Part I: Diseases of the Eyelids; H. Kimpron: London, UK, 1974. [Google Scholar]
  65. Negi, M.; Takemura, T.; Guzman, J.; Uchida, K.; Furukawa, A.; Suzuki, Y.; Iida, T.; Minami, J.; Yamada, T.; Kawachi, H.; et al. Localization of propionibacterium acnes in granulomas supports a possible etiologic link between sarcoidosis and the bacterium. Mod. Pathol. 2012, 25, 1284–1297. [Google Scholar] [CrossRef] [PubMed]
  66. Yasuhara, T.; Tada, R.; Nakano, Y.; Tei, M.; Mochida, C.; Kamei, M.; Kinoshita, S. The presence of Propionibacterium spp. in the vitreous fluid of uveitis patients with sarcoidosis. Acta Ophthalmol. Scand. 2005, 83, 364–369. [Google Scholar] [CrossRef] [PubMed]
  67. Ishige, I.; Usui, Y.; Takemura, T.; Eishi, Y. Quantitative PCR of mycobacterial and propionibacterial DNA in lymph nodes of Japanese patients with sarcoidosis. Lancet 1999, 354, 120–123. [Google Scholar] [CrossRef]
  68. Eishi, Y. Etiologic aspect of sarcoidosis as an allergic endogenous infection caused by Propionibacterium acnes. Biomed Res. Int. 2013, 2013, 935289. [Google Scholar] [CrossRef] [PubMed]
  69. Valeyre, D.; Prasse, A.; Nunes, H.; Uzunhan, Y.; Brillet, P.Y.; Muller-Quernheim, J. Sarcoidosis. Lancet 2014, 383, 1155–1167. [Google Scholar] [CrossRef]
  70. Kumar, V.; Abbas, A.K.; Aster, J.C. Acute and Chronic Inflammation, 9th ed.; Saunders: Philadelphia, PA, USA, 2014. [Google Scholar]
  71. Pagan, A.J.; Ramakrishnan, L. The Formation and Function of Granulomas. Annu. Rev. Immunol. 2018, 36, 639–665. [Google Scholar] [CrossRef]
  72. Yamaguchi, T.; Costabel, U.; McDowell, A.; Guzman, J.; Uchida, K.; Ohashi, K.; Eishi, Y. Immunohistochemical Detection of Potential Microbial Antigens in Granulomas in the Diagnosis of Sarcoidosis. J. Clin. Med. 2021, 10, 983. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Suzuki, T.; Kinoshita, S. Dual Role of Cutibacterium acnes: Commensal Bacterium and Pathogen in Ocular Diseases. Microorganisms 2024, 12, 1649. https://doi.org/10.3390/microorganisms12081649

AMA Style

Suzuki T, Kinoshita S. Dual Role of Cutibacterium acnes: Commensal Bacterium and Pathogen in Ocular Diseases. Microorganisms. 2024; 12(8):1649. https://doi.org/10.3390/microorganisms12081649

Chicago/Turabian Style

Suzuki, Tomo, and Shigeru Kinoshita. 2024. "Dual Role of Cutibacterium acnes: Commensal Bacterium and Pathogen in Ocular Diseases" Microorganisms 12, no. 8: 1649. https://doi.org/10.3390/microorganisms12081649

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop